Category: Cancer (Page 2)
NELSON Trial Reinforces Efficacy of Low-Dose CT Lung Cancer Screening
Based on the results from a recent clinical trial, the guidelines for which patients should be screened for lung cancer may soon change.
Case Study: Toddler with Wilms’ Tumor in Remission After Aggressive Therapy
Wilms’ tumor is the most common type of kidney cancer in children; however, it is a rare diagnosis with approximately 500 cases per year in the U.S. Diffuse anaplastic Wilms’ tumor is a more aggressive subtype of the disease and requires more intensive therapy.
Get to Know: Hematologist Firas El Chaer, MD
Dr. El Chaer specializes in caring for patients with acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia.
5 Tips to Get More Patients Screened for Colorectal Cancer
As providers, we have an opportunity to ensure patients are well informed about why screening is important, when it’s necessary and how it’s done.
Director of the UVA Cancer Center Weighs in on Largest Drop Ever in Cancer Death Rate
In a recent article that appeared on UVA Today, Thomas Loughran, MD, discussed the role UVA has played in furthering this decades-long trend, improving outcomes for cancer patients, as well as advancing the treatment of the disease worldwide through ongoing clinical research.
UVA Expert Featured in Podcast on Oral Therapies and Adherence in Lymphoma and CLL — Listen Today!
Learn the most up-to-date and comprehensive information on oral therapies in lymphoma and chronic lymphocytic leukemia (CLL) by tuning in to a podcast featuring UVA Cancer Center Chief of the Division of Hematology/Oncology Michael E. Williams, MD, ScM.
Get to Know: Department of Urology Chair Kirsten Greene, MD, MAS, FACS
A graduate of UVA, Greene returns to after 20 years on the West Coast. Learn more about her plans to further develop the prostate cancer program at UVA and find out what her research has uncovered for mitigating physician burnout.
UVA Cancer Center Expanding Infusion Center
With the addition of more specialty providers and expanded services, such as clinical trials and stem cell transplants, UVA Cancer Center is making improvements to better accommodate a greater number of patients.
Case Study: Lower Eyelid Melanoma in Situ
To ensure the best outcome, in terms of both disease eradication and preserving the appearance and functionality of the eye, UVA brought together skilled providers from dermatopathology, dermatologic surgery and ophthalmology.
Case Study: UVA Treats First Non-Trial Adult Patient with CAR T-Cell Therapy
CAR T-cell therapy was just approved by the U.S. Food and Drug Administration for commercial use in adult patients with refractory and relapsed lymphoma.